Literature DB >> 16790795

Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.

Shizhen Zhang1, Nicole M Green, Izabela Sitkiewicz, Rance B Lefebvre, James M Musser.   

Abstract

Group A Streptococcus (GAS) is a gram-positive human bacterial pathogen that causes infections ranging in severity from pharyngitis to life-threatening invasive disease, such as necrotizing fasciitis. Serotype M28 strains are consistently isolated from invasive infections, particularly puerperal sepsis, a severe infection that occurs during or after childbirth. We recently sequenced the genome of a serotype M28 GAS strain and discovered a novel 37.4-kb foreign genetic element designated region of difference 2 (RD2). RD2 is similar in gene content and organization to genomic islands found in group B streptococci (GBS), the major cause of neonatal infections. RD2 encodes seven proteins with conventional gram-positive secretion signal sequences, six of which have not been characterized. Herein, we report that one of these six proteins (M28_Spy1325; Spy1325) is a member of the antigen I/II family of cell surface-anchored molecules produced by oral streptococci. PCR and DNA sequence analysis found that Spy1325 is very well conserved in GAS strains of distinct M protein serotypes. As assessed by real-time TaqMan quantitative PCR, the Spy1325 gene was expressed in vitro, and Spy1325 protein was present in culture supernatants and on the GAS cell surface. Western immunoblotting and enzyme-linked immunosorbent assays indicated that Spy1325 was produced by GAS in infected mice and humans. Importantly, the immunization of mice with recombinant Spy1325 fragments conferred protection against GAS-mediated mortality. Similar to other antigen I/II proteins, recombinant Spy1325 bound purified human salivary agglutinin glycoprotein. Spy1325 may represent a shared virulence factor among GAS, GBS, and oral streptococci.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790795      PMCID: PMC1489706          DOI: 10.1128/IAI.00493-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  69 in total

1.  M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Betty Forwick; Nancy P Hoe; James M Musser; James A Talbot
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution.

Authors:  Ichiro Nakagawa; Ken Kurokawa; Atsushi Yamashita; Masanobu Nakata; Yusuke Tomiyasu; Nobuo Okahashi; Shigetada Kawabata; Kiyoshi Yamazaki; Tadayoshi Shiba; Teruo Yasunaga; Hideo Hayashi; Masahira Hattori; Shigeyuki Hamada
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

3.  Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.

Authors:  Stanford T Shulman; Robert R Tanz; William Kabat; Kathleen Kabat; Emily Cederlund; Devendra Patel; Zhongya Li; Varja Sakota; James B Dale; Bernard Beall
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

4.  Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity.

Authors:  Nicole M Green; Shizhen Zhang; Stephen F Porcella; Michal J Nagiec; Kent D Barbian; Stephen B Beres; Rance B LeFebvre; James M Musser
Journal:  J Infect Dis       Date:  2005-07-29       Impact factor: 5.226

5.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice.

Authors:  P Patrick Cleary; Yury V Matsuka; Thu Huynh; Hong Lam; Stephen B Olmsted
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

7.  An amino-terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid.

Authors:  Christopher M Waters; Helmut Hirt; John K McCormick; Patrick M Schlievert; Carol L Wells; G M Dunny
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

8.  Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.

Authors:  J Katz; C C Harmon; G P Buckner; G J Richardson; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Pathogenic potential of environmental Vibrio cholerae strains carrying genetic variants of the toxin-coregulated pilus pathogenicity island.

Authors:  Shah M Faruque; M Kamruzzaman; Ismail M Meraj; Nityananda Chowdhury; G Balakrish Nair; R Bradley Sack; Rita R Colwell; David A Sack
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.

Authors:  B Vlaminckx; W van Pelt; L Schouls; A van Silfhout; C Elzenaar; E Mascini; J Verhoef; J Schellekens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

View more
  37 in total

1.  Identification of a supramolecular functional architecture of Streptococcus mutans adhesin P1 on the bacterial cell surface.

Authors:  Kyle P Heim; Ruby May A Sullan; Paula J Crowley; Sofiane El-Kirat-Chatel; Audrey Beaussart; Wenxing Tang; Richard Besingi; Yves F Dufrene; L Jeannine Brady
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

Review 2.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

Review 3.  A decade of molecular pathogenomic analysis of group A Streptococcus.

Authors:  James M Musser; Samuel A Shelburne
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

Review 4.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

5.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

6.  Elongated fibrillar structure of a streptococcal adhesin assembled by the high-affinity association of alpha- and PPII-helices.

Authors:  Matthew R Larson; Kanagalaghatta R Rajashankar; Manisha H Patel; Rebekah A Robinette; Paula J Crowley; Suzanne Michalek; L Jeannine Brady; Champion Deivanayagam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

7.  Identification and characterization of an antigen I/II homologous gene, pah, from Streptococcus downei.

Authors:  Haruki Tamura; Arisa Yamada; Hirohisa Kato
Journal:  Curr Microbiol       Date:  2008-02-19       Impact factor: 2.188

8.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

9.  Analysis of polymorphic residues reveals distinct enzymatic and cytotoxic activities of the Streptococcus pyogenes NAD+ glycohydrolase.

Authors:  Sukantha Chandrasekaran; Joydeep Ghosh; Gary C Port; Eun-Ik Koh; Michael G Caparon
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

10.  Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens.

Authors:  Milene Tavares Batista; Renata D Souza; Juliano D Paccez; Wilson B Luiz; Ewerton L Ferreira; Rafael C M Cavalcante; Rita C C Ferreira; Luís C S Ferreira
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.